EUDA Health Holdings Cash Flow from Financial Activities 2022-2024 | EUDA

EUDA Health Holdings cash flow from financial activities from 2022 to 2024. Cash flow from financial activities can be defined as the net amount of cash transactions used in funding activities
EUDA Health Holdings Annual Cash Flow Financial
(Millions of US $)
2024 $2
2023 $2
2022 $2
2021 $0
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.147B $0.004B
EUDA Health Limited is a health technology company which operates southeast Asian digital healthcare ecosystem. The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians and predicts optimal treatment outcomes. Its holistic approach supports patients throughout all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions and aftercare services. EUDA Health Limited, formerly known as 8i Acquisition 2 Corp., is based in Singapore.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.307B 54.29
Hims & Hers Health (HIMS) United States $13.112B 136.23
Tempus AI (TEM) United States $10.781B 0.00
IRhythm Technologies (IRTC) United States $4.503B 0.00
Inspire Medical Systems (INSP) United States $4.415B 68.98
Privia Health (PRVA) United States $3.036B 207.50
Enovis (ENOV) United States $2.041B 11.38
Clover Health Investments (CLOV) United States $1.735B 0.00
Schrodinger (SDGR) United States $1.706B 0.00
Phreesia (PHR) United States $1.529B 0.00
Omnicell (OMCL) United States $1.315B 23.21
Azenta (AZTA) United States $1.223B 56.83
10x Genomics (TXG) United States $1.125B 0.00
Fulgent Genetics (FLGT) United States $0.610B 0.00
Butterfly Network (BFLY) United States $0.569B 0.00
Talkspace (TALK) United States $0.500B 149.50
Veradigm (MDRX) United States $0.482B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.399B 0.00
TruBridge (TBRG) United States $0.368B 816.67
Health Catalyst (HCAT) United States $0.286B 0.00
Nyxoah SA (NYXH) Belgium $0.212B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.207B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.117B 0.00
MDxHealth SA (MDXH) Belgium $0.090B 0.00
CareCloud (CCLD) United States $0.086B 3.27
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.039B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00